密集血压控制对大动脉膜疾病中左心室缩的影响
Mijin Kim1, Jung-Hyun Choi2, Hyung-Kwan Kim3
1Division of Cardiology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Republic of Korea.
American heart journal
|November 25, 2023
概括
密集的血压控制显著降低了左心室 (LV) 缩在患有大动脉病的患者. 这一发现表明,对这些人来说,更严格的BP管理有好处.
科学领域:
- 心脏病学 心脏病学
- 高血压管理 高血压管理
- 膜心脏疾病 膜心脏疾病
背景情况:
- 高血压加剧左心室 (LV) 压力过载在患有大动脉 (AV) 疾病的患者.
- 对AV病患者的最佳血压 (BP) 目标尚未明确.
- 研究密集血压控制对AS或AR患者的LV缩的影响.
研究的目的:
- 为了确定密集的血压控制是否可以降低无症状的大动脉狭窄症 (AS) 或大动脉吐症 (AR) 的无症状患者的LV缩.
主要方法:
- 128名患有轻度至中度AS或AR的高血压患者被随机分配到密集的血压治疗 (静脉压<130毫米) 或标准治疗 (静脉压<140毫米).
- 主要终点:24个月LV质量的变化.
- 二级终点:动脉动脉疾病严重程度的变化,LV体积,喷射分数和全球纵向应变 (GLS).
主要成果:
- 强化治疗组在24个月内实现了标准治疗组的平均静脉血压为129 mm Hg,而标准治疗组的平均静脉血压为135 mm Hg.
- 与标准治疗组 (10.3 g) (P=.0007) 的增加相比,密集治疗组 (-3.9 g) 的LV质量显著下降 (P=.0007).
- 两组之间没有观察到二次终点或AV疾病进展的显著差异.
结论:
- 强化高血压治疗显著降低了AV疾病患者的LV缩.
- 在密集和标准血压控制组之间,AV疾病的进展类似.
- 更严格的血压控制可能有利于管理AV疾病的高血压患者的LV缩.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Heart Failure Drugs: β-Blockers
342
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
342
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
654
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
654
Antihypertensive Drugs: Angiotensin II Receptor Blockers
748
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
748
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K


